Should oral anticoagulation be discontinued after 3 months in the setting of a first high-risk pulmonary embolism secondary to a major transient/reversible risk factor?

Important recommendations for the regimen and duration of anticoagulation after pulmonary embolism (PE) are proposed in the new/revised concepts in the 2019 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines for the diagnosis and management of acute pulmonary embolism. Potential indications for extended anticoagulation, after initial therapeutic anticoagulation for at least 3 months, depend on the presence of risk factors.

Source: European Respiratory Journal - January 29, 2020 Category: Respiratory Medicine Authors: Slabbynck, H., Clukers, J., Galdermans, D. Tags: Original Articles: Correspondence Source Type: research